Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
This study is not yet open for participant recruitment.
Verified March 2012
by Beijing Northland Biotech. Co., Ltd.
Study NCT01548378 Information provided by Beijing Northland Biotech. Co., Ltd.
First Received on March 5, 2012. Last Updated on April 9, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Sponsors listed in this trial
Beijing Northland Biotech. Co., Ltd.
ViroMed Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers